• VPR Brands develops products for the vaping market
• The company recently launched its new dry-herb vaporizer
• VPR continues to experience strong financial results as it builds its product portfolio

VPR Brands LP (OTC: VPRB) is a technology holding company based in Fort Lauderdale, Florida, that continues to drive scale across diverse high-growth verticals. With its award-winning design and diligent product innovation, VPR Brands offers investors a gateway to the vape products marketplace.

VPR Brands boasts an extensive portfolio of tested vaporizer products. Its product suite includes Helium, HoneyStick, Vaporin, Vaporx, GoldLine and GoldLine Hemp products and brands. VPR is taking advantage of a line of CBD (cannabidiol) products to boost growth and gain market share in the cannabis-consumables sector. The company has likewise reported robust year-over-year financial growth, with room for margin improvement, as well as category growth (http://ibn.fm/iHdTq).

Recently, VPR Brands announced the launch of its HRB Turbo Dry Herb Vaporizer by HoneyStick. The HRB Turbo is an ultra-premium, pocket-sized, dry-herb vaporizer that’s available for $99. “The HRB Turbo is the best dry-herb vaporizer with an MSRP under $100 currently on the market,” VPR Brands COO Dan Hoff stated in a news release (http://ibn.fm/8c46d). “The luxurious feel and performance of the unit makes it truly a great value for anyone on the market for a top-tier pocket vaporizer that doesn’t want to spend an arm and a leg. With many of our clients requesting us to make more products for dry herb, it’s a perfect fit into our product line.”

CNW420 recently reported on New Mexico cannabis decriminalization following signing of a bill by New Mexico Governor Michelle Grisham that took effect on July 1, 2019. This law makes New Mexico the 24th state to decriminalize marijuana. Governor Grisham has promised to pursue marijuana legalization in New Mexico. She has created a working group to study legalization in other states and prepare recommendations about the best way to handle legalization next year. Cannabis industry commentators believe that industry participants, including VPR Brands, will be relieved that New Mexico has provided good news to break the chain of legislative setbacks (http://ibn.fm/PvFz5).

VPR Brands has developed a curated product mix to drive sales. That mix includes vaporizers, e-liquids, cannabis consumables, disposable vapes, batteries and tanks. Together, this product mix works to meet consumers’ needs and create synergies across the company’s brands.

VPR is seeing growth, including quarterly revenues that increased by roughly 31 percent year-over-year to $1.3 million. Moreover, the company slightly decreased its net loss from about $149,000 in Q1 2018 to approximately $138,000 in Q1 2019. VPR also continues to maintain healthy gross operating margins of greater than 40 percent (http://ibn.fm/O9aCd).

VPR Brands also reported positive financial results for full-year 2018, including increased revenues totaling an estimated $4.6 million. In addition, the company reversed its operating loss of more than $888,000 into positive territory above $9,000. Full-year 2018 gross operating margins rose by nearly 20 percent from 2017 to a margin of 41 percent last year (http://ibn.fm/KeO2S).

Company assets include issued U.S. and Chinese patents for atomization-related products. Its patents include technology for medical marijuana vaporizers and electronic cigarette products and components. Additionally, the company engages in product development for the vapor and vaping market, including e-liquids. VPR Brands has a seasoned management team with wide-ranging experience in the vaporizer category.

For more information, visit the company’s website at www.VPRBrands.com

NOTE TO INVESTORS: The latest news and updates relating to VPRB are available in the company’s newsroom at http://ibn.fm/VPRB

• Trxade Group subsidiary Community Specialty Pharmacy received certification from LegitScript following a rigorous application and review process
• Over 10,500 independent pharmacies are registered on Trxade’s S2P (supplier to pharmacy) pharmaceuticals trading platform
• The company’s first quarter 2019 revenues increased to a record $1.5 million

Trxade Group Inc. (OTCQB: TRXD), an integrated pharmaceutical services company, is focused on three key niches in the health care market, a $4 trillion industry that’s expected to grow as the general population ages. TRXD offers a unique combination of a web-based purchasing platform for transactions between independent pharmacists and drug distributors; a network of pharmacies with E-Hub software; a mail order pharmacy; and warehouse and drug delivery services.

TRXD is off to a record start this fiscal year, with reported Q1 2019 sales of $1.5 million (http://ibn.fm/lbyhN). Revenue growth was attributed to an increase in fees generated from the company’s supplier-to-pharmacy trading platform and increased pharmaceutical sales from its wholly owned subsidiary, Community Specialty Pharmacy LLC.

In Q1 2019, TRXD added more than 400 new independent pharmacies to the Trxade software trading platform, bringing the membership total to over 10,500 pharmacies. There are more than 24,000 independent pharmacies in the United States with combined pharmaceutical purchases of $93 billion per year.

“Our proprietary software trading platform at www.Trxade.com, which enables independent pharmacies to purchase drugs, is adding new members on a monthly basis and, as a result, is enabling us to experience strong top and bottom-line growth across the board,” Trxade Group Chairman and CEO Suren Ajjarapu said in a news release.

Community Specialty Pharmacy (“ComspRx”) has carved out a niche in the highly competitive pharmacy industry with a patient-driven approach. Importantly, ComspRx has secured LegitScript certification following a rigorous review process. LegitScript approval is known throughout the online advertising, social media, regulatory and payment sectors and is recognized by Visa, Mastercard, Google, Bing and others. Certification lets customers know ComspRx is committed to best-in-class pharmacy programs and operates safely and legally in a highly regulated health care marketplace, as TXRD noted in a news release (http://ibn.fm/mwkZQ).

“LegitScript certification is another way for us to help consumers understand their options and choose a pharmacy that has their best interests, and long-term health in mind,” Ajjarapu said in a news release, adding that ComspRx is dedicated to assessing a patient’s unique requirements and prescriptions and providing top-tier, comprehensive and compassionate care.

For more information, visit the company’s website at www.TrxadeGroup.com

NOTE TO INVESTORS: The latest news and updates relating to TRXD are available in the company’s newsroom at http://ibn.fm/TRXD

• Golden Developing Solutions has strategically integrated its CBD-related services and ventures
• DVLP recently launched an online portal and websites to strengthen its online presence
• The worldwide legal cannabis market is expected to reach $146 billion by the end of 2025

Golden Developing Solutions Inc. (OTC: DVLP) has strategically integrated all functioning entities under one management roof (http://ibn.fm/sp2cQ). This move is expected to add more structure to the company, as all divisions will be under the supervision of a central organization, leading to better growth and higher returns on investment. DVLP CEO Stavros Triant stated that all brands under DVLP will function in collaboration with each other, realizing the potential of every department to its fullest.

“We’re in a pivotal period of growth in which every department, no matter its specialty, is working at its highest and best use to more effortlessly sustain our success,” Triant said in a news release. “No longer are brands working in silos; rather, they are working under one roof, where collaboration is at an all-time high.”

With the vertical integration of the company’s entities, DVLP’s internal management has taken over the marketing responsibility for CBD Infusionz and Where’s CBD, two DVLP brands, in an effort to streamline CBD-related business activities across the United States. As part of its expansion strategy, DVLP has launched CBD Infusionz’s user-friendly website, which enables consumers to seamlessly navigate and search for cannabis, along with other CBD-related products and information.

DVLP is a developing-stage company that deals in CBD products and related services and businesses. The company also operates an ancillary software unit and is developing an online retail market for CBD, hemp oil and related health and wellness products. Golden Developing Solutions also focuses on acquiring CBD-related companies in accordance with state and federal laws.

In 2018, Golden Developing Solutions acquired Where’s Weed, a cannabis technology company that connects medical and recreational cannabis users with local cannabis suppliers. The company’s primary asset is a sophisticated mobile app, which has nearly three million pageviews per month. The app is a community-based resource focused on supplying information to cannabis users.

The growth and acceptance of cannabis and CBD products in Canada and the United States have been the motivation for DVLP’s digital expansion plans and its foray into CBD-related health and wellness product ventures, the C-store snack market and other ancillary markets. The worldwide legal cannabis market is expected to reach $146 billion by the end of 2025 (http://ibn.fm/TFW7t).

For more information, visit the company’s website at www.GoldenDeveloping.com

NOTE TO INVESTORS: The latest news and updates relating to DVLP are available in the company’s newsroom at http://ibn.fm/DVLP

• ETST product sales rose to $770,635 for fiscal 2019, up from $463,108 in the previous year
• The company cited expanded distribution, increased customer awareness and rising demand for branded, high-grade, full-spectrum cannabinoid products as reasons for the improvement
• ETST’s cost of revenue rose as sales grew, but the company maintained a gross margin of 38.2 percent for the fiscal year

Earth Science Tech Inc. (OTCQB: ETST), a biotech company focused on the nutraceutical and pharmaceutical fields, reported a 66.4 percent rise in revenues to $770,635 for the 12 months ended March 31, as compared to $463,108 for the same period in 2018 (http://ibn.fm/jmGx4).

In an annual report, filed with the SEC in July 2019, the company cited expanded distribution, increased customer awareness and rising demand for its branded, high-grade, full-spectrum cannabinoid products as factors driving the impressive performance. By cutting expenses from rising costs as product sales rose, ETST was able to maintain a 38.2 percent gross margin, the report noted, in addition to seeing a 52.9 percent jump in gross profit – from $192,886 in FY2018 to $295,013 in FY2019.

Details of the report show a 179 percent decline in bad debt expense, marking a savings of $56,131 as compared to $31,211 from the prior year. ETST also reported sharply higher sales and an efficient 37 percent cut in marketing expenses to $242,719 in FY2019 from $332,986 in FY2018.

ETST markets a line of full-spectrum cannabinoids available for shipping to all 50 U.S. states. Sales are made online from the company’s website, as well as through its storefront and clinic accounts. ETST products contain only natural ingredients, use CBD oil extracted through a CO2 formulation and include flavors ranging from peppermint to orange blossom.

Arcview Market Research projects that legal cannabis sales in North America will reach $20.2 billion by 2021, growing at a compound annual growth rate (CAGR) of 25 percent from 2016, as reported by BioSpace (http://ibn.fm/PdZUI).

For more information, visit the company’s website at www.EarthScienceTech.com

NOTE TO INVESTORS: The latest news and updates relating to ETST are available in the company’s newsroom at http://ibn.fm/ETST

• Technical420 is bullish on aggressive growth as Plus Products expands into Nevada through a definitive agreement with TapRoot Holdings
• Entry into Nevada is forecast to be a growth driver for the company and a key step toward building an internationally recognized brand
• PLUS is also purchasing an option to buy cannabis oil producer Emerald Bay Wellness and the business assets of Emerald Bay Extracts

Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF), manufacturer and marketer of cannabis food products, was identified as a ‘premier edibles brand to watch’ in a bullish analysis by Technical420 that cites the company’s growth into Nevada from its California base (http://ibn.fm/QwSZ2).

According to cannabis market analysis by Anthony Varrell of Technical420, PLUS’ move beyond California after dominating edibles in that market is significant. “One of the biggest potential catalysts for Plus Products will be the expansion into additional cannabis markets in the U.S. The company has been laser focused on the California opportunity, and we have been favorable about this approach since we started covering this company,” he said in an article. “Going forward, we would expect to see Plus Products announce a strategic partner when it comes to conducting a national expansion and this is something to be watching.”

Varrell also sees the PLUS expansion beyond California into Nevada as a major development in its growth. Technical420 analysis concludes that PLUS Products is a ‘premier edibles brand to watch’, citing the company’s domination of the California market as a solid foundation for what it sees as a growth driver for the company as it expands into Nevada, especially the Las Vegas market. PLUS has made those moves through its definitive agreement with TapRoot Holdings, a vertically integrated cannabis company.

PLUS has also purchased an option to buy one of its largest cannabis-oil suppliers, Emerald Bay Wellness LLC, along with the business assets of Emerald Bay Extracts. The option specifies cash and stock consideration for the acquisition (http://ibn.fm/oJSBM). The option grants PLUS the right, but not the obligation, to buy.

PLUS said that if the option is exercised, the acquisition would give PLUS in-house cannabis extraction capabilities that would improve quality control and raise gross margins on its core-edibles business. The move would also create a new revenue stream and capabilities for new-product development.

San Mateo, California-based PLUS is a cannabis-infused, branded-products manufacturer selling to regulated medicinal and adult-use recreational markets in California and Nevada. PLUS is focused on building the largest cannabis brand by growing organically and through acquisitions.

For more information, visit the company’s website at www.PlusProducts.com

NOTE TO INVESTORS: The latest news and updates relating to PLPRF are available in the company’s newsroom at http://ibn.fm/PLPRF

• The electric vehicle market continues to grow faster than originally anticipated
• Roughly 57 percent of passenger vehicle sales and 56 percent of light commercial vehicle sales are expected to be electric by 2040
• These market conditions create excellent opportunities for QMC Quantum Minerals, which is strategically positioned for lithium production

The global demand for lithium will continue growing at a rapid pace, increasing to one million tons per year by 2025 from the current 325,000 tons, according to a recent BloombergNEF report (http://ibn.fm/2ZwKR). The autonomous electric vehicles market is, of course, one of the primary drivers of growth.

According to BloombergNEF’s report titled ‘Electric Vehicle Outlook 2019’, over two million electric vehicles were sold in the world in 2018, marking a massive increase from the few thousand cars sold eight years prior. The analysis suggests that, by 2040, 57 percent of all passenger vehicles sales and over 30 percent of the global passenger vehicle fleet will be electric.

Statistics also suggest that the electric vehicle trend is spreading to multiple segments. By 2040, 56 percent of light commercial vehicles sales are forecast to be electric, and the same applies to 31 percent of medium commercial vehicle sales in the U.S., China and Europe.

Such forecasts outline excellent opportunities for mineral explorers like QMC Quantum Minerals Corp. (TSX.V: QMC) (OTC: QMCQF) (FSE: 3LQ). The company continues to build its range of options to meet these new opportunities and strengthen its lithium production.

QMC’s Irgon Lithium Mine project in southeast Manitoba is close to the completion of a NI 43-101 resource estimate for the potential commercial development of lithium and other minerals. Previously, the Irgon Lithium Mine project has shown exceptional potential for commercial lithium extraction on the basis of historic estimates. These suggest a mineral estimate of 1.2 million tons grading 1.51 percent lithium oxide over a strike length of 365 meters (1,197.5 feet) and to a depth of 213 meters (698.8 feet).

QMC Quantum Minerals, however, isn’t relying solely on the area encompassed in the historic estimate. The company has expanded the potential of other dikes within the project. Surface sampling has confirmed the potential of the Mapetre, Central and Irgon West dikes for additional tonnage.

Via resampling, QMC Quantum Minerals estimated the presence of up to 0.32 percent lithium oxide over 16.61 meters (54.5 feet) in the Mapetre dike, including 0.52 percent Li2O over 8.69 meters (28.5 feet) (http://ibn.fm/ZIrcV).

The Mapetre and Central dikes are located at opposite ends of a 1,100-meter-long and 100- to 350-meter wide target area. As a result, QMC expects the identification of additional, large spodumene-bearing pegmatite dikes within the zone. Such discoveries are anticipated during the 2019 field season, allowing QMC to make full use of new market dynamics and position itself as a lithium production leader and an attractive opportunity for investors interested in this fast-growing mineral market.

For more information, visit the company’s website at www.QMCMinerals.com

NOTE TO INVESTORS: The latest news and updates relating to QMCQF are available in the company’s newsroom at  http://ibn.fm/QMCQF

• The company has 25 million common shares issued and outstanding
• Canadian Securities Exchange trading began on July 10, 2019
• The listing is anticipated to lead to new opportunities for MustGrow and its signature biopesticide and biofertilizer technologies
• The cannabis market is seen as a major opportunity for MustGrow technologies

Agricultural biotech company MustGrow Biologics Corp. (CSE: MGRO) recently received Canadian Securities Exchange (CSE) approval for the listing of its common shares. The shares began trading on the CSE under ticker symbol ‘MGRO’ on July 10, 2019 (http://ibn.fm/AENk6).

The company has 25 million common shares issued and outstanding and 36.9 million on a fully diluted basis. The CSE listing follows a recent non-brokered private placement of common shares at a price of $0.70 per share, which generated gross proceeds of $1.2 million (http://ibn.fm/N2CIS). The proceeds are being used to accelerate research and development of the company’s formulations, for working capital and for other corporate purposes.

MustGrow is currently focused on the development and commercialization of its natural biopesticide and biofertilizer technologies. These provide an effective, safe and natural solution to fruit, vegetable, turf and ornamental industry farmers interested in growing healthy crops that are free from synthetic pesticide traces.

The company refines its biopesticides and biofertilizers from compounds of the mustard plant. These compounds are effective fungicides, pesticides and nematicides, as well as having fertilizer properties to ensure sustainable plant growth across a wide range of crops. The mustard plant is recognized for its natural defense mechanism. When the organic compounds from the plant are combined with water, they form allyl isothiocyanate (AITC) – the active ingredient in the MustGrow range of products. According to the company, AITC has huge potential to benefit agricultural production. Its full range of effects is yet to be explored and fully commercialized.

MustGrow has concentrated AITC in granular and liquid forms, both of which ensure safety and effectiveness. The granular product is EPA-approved in the U.S. as both a biofertilizer and biopesticide, apart from California where it is approved solely as a fertilizer. In Canada, the product has received Health Canada Pest Management Regulatory Agency (PMRA) approval as a fruit, vegetable, turf and ornamental biofertilizer and biopesticide.

Product testing has demonstrated the high level of effectiveness of the MustGrow biopesticide and biofertilizer. Validated free trial results include 100 percent control of root-knot nematodes in strawberry crops, 95 percent control of Pythium root rot in lettuce fields, a 70 percent reduction in Verticillium root severity in cucumbers and a 55 percent increase in tomato crop yields.

Apart from working on its signature products, MustGrow is compiling a science-based suite of biological products by assessing third party potential product labels. These include natural biopesticides and biofertilizers. MustGrow is striving to achieve in-licensing private labels, as well as the distribution of third-party products to Canadian cannabis growers exclusively through MustGrow.

These developments, paired with the company’s CSE listing, are anticipated to bring new opportunities to MustGrow and help the company cement its position on the fast-growing global biopesticides market. The market is projected to expand at an annual rate of 15.99 percent, reaching $6.4 billion, by 2023 (http://ibn.fm/4dfWU). Advancements in integrated pest management solutions and the increasing adoption of organic farming will both contribute to the market’s rapid growth.

In particular, the cannabis market is seen as a major opportunity for MustGrow technologies. The legal U.S. marijuana industry is expected to grow to $21.8 billion by 2020, and yet it faces significant challenges:

• There are no uniform guidelines for pesticide use in the cannabis industry.
• Cannabis plants are prone to pests and disease, which can spawn a new generation in less than a week and spread rapidly.
• Growers have taken the matter into their own hands, treating their plants with alarmingly high levels of pesticides intended for other uses.
• Many cannabis products contain pesticides at levels higher than what’s typically allowed for edible or combustible products.
• Extracting concentrates, used to produce edibles, tropical products and inhalants, cause pesticide residues to accumulate at levels that are 10-times higher than those of flowers.
• Regulated medical-marijuana companies are facing proposed class-action lawsuits from patients who unknowingly ingested banned pesticides.

MustGrow offers reliable, safe, scientifically studied and approved biodegradable solutions to enhance, protect and adhere to regulations.

For more information, visit the company’s website at www.MustGrow.ca

NOTE TO INVESTORS: The latest news and updates relating to MGRO are available in the company’s newsroom at http://ibn.fm/MGRO

• TGOD is expanding into the global organic-hemp CBD market with its Global Strategic Hemp Division; the global CBD market is forecast to reach $22 billion in three years
• The company’s flagship Quebec facility received organic certification from Pro-Cert; the site is slated to reach more than 1.3 million square feet
• TGOD plans to enter the U.S. hemp-CBD beverage market through existing partnerships

The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) is entering the global hemp-CBD market by debuting its Global Strategic Hemp Division. The move will leverage the company’s expertise in the European hemp-CBD market across its established network of international partners (http://ibn.fm/DtLB0).

TGOD estimates that the global CBD market will reach $22 billion in less than three years. TGOD will move into the global sector as the demand for high-quality hemp-CBD products in Europe grows. In 2018, TGOD acquired HemPoland, which has an expanding footprint and distributor network across Europe. This move is expected to provide an advantage to market entry for TGOD.

“Our team has years of direct hands-on experience in the CBD space,” TGOD CEO Brian Athaide stated in a news release (http://ibn.fm/RZ0oF). “We are excited to use this advantage to execute on a fast-moving market expansion strategy.”

That strategy includes several initiatives, including expansion in Canada, Germany, Jamaica, Mexico, Poland and the United States. For its entry into the U.S. market, TGOD has developed a suite of hemp-CBD products, including CBD-infused beverages. The company’s approach enables TGOD to enter the American hemp-CBD market quickly and with a capital-light business model.

TGOD has also received organic certification from Pro-Cert for its Valleyfield, Quebec, facility. TGOD anticipates that, when completed, that location will reach 1.3 million square feet and become the largest organic cannabis greenhouse in the world (http://ibn.fm/3a20h). The company already has certified organic growing facilities in Europe and Canada.

TGOD noted that Pro-Cert’s certification programs are ISO 17065 compliant and accredited, offering global recognition and international access to the brands and products it certifies.

Toronto-based TGOD is a premium, global, organic-cannabis company with operations focused on medical cannabis markets in Canada, Europe, the Caribbean and Latin America, as well as the Canadian adult-use market. Through wholly owned subsidiary HemPoland, TGOD distributes premium hemp-CBD oil in the European Union.

For more information, visit the company’s website at www.TGOD.ca

NOTE TO INVESTORS: The latest news and updates relating to TGODF are available in the company’s newsroom at http://ibn.fm/TGODF

• The shifting retail industry is creating new opportunities in direct-selling
• Remote employment and work-from-home positions are projected to make up the majority of the U.S. workforce by 2027
• The company is focused on elevating entrepreneurs with much-needed resources in the ever-growing global direct-selling market

A quick search of the retail industry suggests that the sector is dying, as stores such as Payless, Walgreens, JCPenny, Victoria Secret and more announce closures. However, a closer look reveals that the industry is not dying; it is merely changing. People are skipping crowded malls and shops and opting for the ease of e-commerce and the comfort of direct-selling. According to Statista, the direct-selling market brought in $64 billion in the Americas, with wellness products leading the way with 33.8 percent of total industry sales. An estimated 20.5 million people are involved in direct-selling in the United States, marking a 31 percent increase over a five-year period (http://ibn.fm/dZ7mZ).

The United States is also experiencing a shift toward entrepreneurship and working remotely. Companies specializing in the direct-selling industry, such as Sharing Services Global Corporation (OTCQB: SHRG), are ready for the influx. According to a comprehensive study by Upwork and Freelancers Union, freelancers are projected to make up the majority of the U.S. workforce by 2027 (http://ibn.fm/6sWZq). Freelancing is attractive because it offers individuals freedom to choose their own hours and work locations. However, the option also comes with challenges, such as a lack of health care, sick days and vacation.

SHRG is working to make direct-selling more appealing to the entrepreneur than freelancing. The company is doing this by successfully providing access to much-needed benefits while still offering the freedom of schedule and location. The company coined the term elepreneurs to represent its mission to elevate the lives of its independent distributors through products and services.

Individuals with an entrepreneurial drive who are looking into the direct-selling industry will find professionalism at every turn. The company provides home-based entrepreneurs in the U.S. and others countries with access to insurance, wholesale travel, wellness products, live and online seminars and training events, and unique compensation and reward programs. The company offers a wide range of products and services catered to today’s consumer. This approach helps to generate 100 percent organic growth.

SHRG has identified four specific keys to success that it has continued to build on since launching Elepreneurs and Elevacity Global in December 2017:

1. Attract and retain driven entrepreneurs and shape how home-based Elepreneurs succeed;
2. Continue to expand its holdings portfolio;
3. Rely on the expert guidance of a proven core leadership team; and
4. Capitalize on the forecast growth of the direct-selling industry.

The company’s competitive advantage lies in its wellness products, which are scientifically formulated to stimulate happiness, as well as a unique shared compensation model that creates loyalty and rapid organic growth. By empowering Elepreneurs with freedom, choice and support, SHRG and its subsidiaries are well positioned in an ever-growing global direct-selling market. In the last few months alone, SHRG has grown by thousands of independent sales representatives.

For more information, visit the company’s website at www.SHRGInc.com

NOTE TO INVESTORS: The latest news and updates relating to SHRG are available in the company’s newsroom at http://ibn.fm/SHRG

• On July 2, PLUS warrants and debentures began trading on the Canadian Securities Exchange under ticker symbols ‘PLUS.DB’ and ‘PLUS.WT’
• The warrants and debentures were part of a brokered private placement that closed in February 2019, raising gross proceeds of C$25 million
• Plus Products is a San Mateo, California-based manufacturer and marketer of cannabis food products; it has grown from its California base into Nevada

Plus Products Inc.’s (CSE: PLUS) (OTCQX: PLPRF) debentures and warrants from its brokered private placement that closed February 28, 2019, were listed, beginning July 2, on the Canadian Securities Exchange under ticker symbols ‘PLUS.DB’ and ‘PLUS.WT’ (http://ibn.fm/GpEOX). The warrants and debentures were part of a private placement that raised C$25 million, with the funds to be used for working capital and other general corporate purposes.

The private placement of unsecured convertible note units closed on February 28 (http://ibn.fm/yxOqU). The brokered private placement of 25,000 units of the company at a price of C$1,000 per unit consisted of one unsecured convertible debenture having the principal amount of C$1,000 and 77 subordinate voting share purchase warrants of the company.

Every debenture accrues interest at eight percent per year, payable semiannually in arrears until the February 21, 2021, maturity date. They are also convertible into subordinate voting shares at C$6.50 per conversion share starting September 28, 2019. The debentures are unsecured obligations of the company.

Each warrant entitles the holder to acquire one subordinate voting share at a C$8 exercise price per warrant share until February 28, 2024. If exercised during the one-year period from February 28, 2019, the warrant shares will be subject to a 365-day contractual hold from February 28, 2019.

San Mateo, California-based PLUS is a cannabis-infused branded products manufacturer selling to regulated medicinal and adult-use recreational markets in its home-base market of California and Nevada. PLUS is focused on building the largest cannabis brand by growing organically and through acquisitions.

For more information, visit the company’s website at www.PlusProducts.com

NOTE TO INVESTORS: The latest news and updates relating to PLPRF are available in the company’s newsroom at http://ibn.fm/PLPRF